For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Amebocyte Lysate is an aqueous extract of blood cells from the Atlantic horseshoe crab or oriental horseshoe crab. Amebocyte Lysate reacts with bacterial endotoxin lipopolysaccharide (LPS), which is a membrane component of gram negative bacteria. This reaction is the basis of the Amebocyte Lysate test, which is then used for the detection and quantification of bacterial endotoxins.
Scope of the Report:
Amebocyte Lysate is widely used in Drug Testing, Clinical Diagnosis and other field. The most proportion of Amebocyte Lysate is Drug Testing, and the proportion in 2016 is 52%. The trend of Drug Testing is stable.
Europe is the largest supplier of Amebocyte Lysate, with a production market share nearly 50% in 2016. United States is the second largest supplier of Amebocyte Lysate, enjoying production market share nearly 25% in 2016.
Market competition is not intense. LONZA, Charles River Laboratories and Associates of Cape Cod are the leaders of the industry.
The worldwide market for Amebocyte Lysate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Amebocyte Lysate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- LONZA
- Charles River Laboratories
- Associates of Cape Cod
- Xiamen Bioendo Technology
- Zhanjiang A&C Biological
- Zhanjiang Bokang
- Fuzhou Xinbei
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Limulus Amebocyte Lysate
- Tachypleus Amebocyte Lysate
Market Segment by Applications, can be divided into
- Drug Testing
- Clinical Diagnosis
- Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Amebocyte Lysate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Amebocyte Lysate, with price, sales, revenue and global market share of Amebocyte Lysate in 2017 and 2018.
Chapter 3, the Amebocyte Lysate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Amebocyte Lysate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Amebocyte Lysate market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Amebocyte Lysate sales channel, distributors, customers, research findings and conclusion, appendix and data source.